IVST: AI 评分 45/100 — AI 分析 (4月 2026)

Innovest Global, Inc. operates across commercial and industrial, energy, and biotechnology sectors. The company designs curtain wall systems, supplies safety equipment, provides energy services, and develops immunotherapeutics.

Key Facts: AI Score: 45/100 Sector: Industrials

公司概况

概要：

Innovest Global, Inc., operating within the industrials sector, focuses on diverse business lines including curtain wall systems, energy services, and biotechnology. With a presence in commercial and industrial sectors, the company also supplies safety equipment and develops immunotherapeutics, positioning itself as a diversified conglomerate.

IVST是做什么的？

Innovest Global, Inc., established in 1999 and based in Chesterland, Ohio, operates as a diversified conglomerate engaging in commercial and industrial, energy, and biotechnology and health services sectors. Originally named Aurum Resource and Asset Management, Inc., the company rebranded to Innovest Global, Inc. in January 2017. Its commercial and industrial segment designs, engineers, tests, and manufactures curtain wall systems, along with negotiating and purchasing various exterior building products. It also supplies personal protection equipment, apparel, and safety supplies. In the energy sector, Innovest Global provides energy services aimed at reducing businesses' overall energy costs, offers LED lighting products, and acts as an independent energy broker. The biotechnology and health services segment focuses on developing immunotherapeutics for treating patients with glioblastoma multiforme. The company also offers inbound and outbound call services.

IVST的投资论点是什么？

Innovest Global, Inc. presents a high-risk, high-reward investment profile due to its presence in multiple sectors, including biotechnology. The company's negative P/E ratio and profit margin of -59.3% indicate financial challenges. Growth catalysts include potential advancements in its immunotherapeutic development and expansion of its energy services. However, the company's OTC listing and negative beta of -0.72 suggest volatility and limited correlation with the broader market. Investors should closely monitor the company's ability to improve profitability and capitalize on its diverse business segments.

IVST在哪个行业运营？

Innovest Global, Inc. operates within the industrials sector, specifically as a conglomerate. This sector is characterized by companies with diverse business operations across multiple industries. The competitive landscape includes companies like BCND, CBCA, LSCG, MEGH and MGLI. Market trends include increasing demand for energy-efficient solutions and advancements in biotechnology. Innovest Global's diversified approach allows it to capitalize on various market opportunities, but also presents challenges in managing diverse operations and maintaining profitability.

Conglomerates

Industrials

IVST有哪些增长机遇？

Expansion of Energy Services: Innovest Global has the opportunity to expand its energy services to meet the growing demand for energy-efficient solutions. The energy services market is projected to reach $120 billion by 2028, driven by increasing awareness of energy conservation and government incentives. By leveraging its expertise in LED lighting and energy brokerage, Innovest can capture a larger share of this market. Timeline: Ongoing.
Development of Immunotherapeutic for Glioblastoma Multiforme: The company's development of immunotherapeutic for glioblastoma multiforme represents a significant growth opportunity. The global glioblastoma multiforme treatment market is expected to reach $2.5 billion by 2027. Successful development and commercialization of this therapeutic could generate substantial revenue. Timeline: 3-5 years.
Increased Demand for Curtain Wall Systems: Innovest Global can capitalize on the increasing demand for curtain wall systems in commercial and industrial construction. The global curtain wall market is projected to reach $50 billion by 2025, driven by urbanization and the need for energy-efficient building solutions. By enhancing its design and manufacturing capabilities, Innovest can secure more projects. Timeline: Ongoing.
Supply of Personal Protective Equipment (PPE): The ongoing need for personal protective equipment (PPE) presents a sustained growth opportunity. The global PPE market is expected to remain strong due to health and safety regulations. Innovest Global can expand its supply chain and distribution network to meet this demand, focusing on quality and competitive pricing. Timeline: Ongoing.
Strategic Partnerships and Acquisitions: Innovest Global can pursue strategic partnerships and acquisitions to expand its market reach and service offerings. Collaborating with other companies in the energy, construction, and biotechnology sectors can provide access to new technologies, markets, and expertise. Targeted acquisitions can complement its existing business lines and accelerate growth. Timeline: 1-3 years.

Operates in diverse sectors including commercial and industrial, energy, and biotechnology.
Gross Margin of 34.0% indicates potential for profitability in specific segments.
Negative Profit Margin of -59.3% reflects current financial challenges.
Market Cap of $0.00B indicates a micro-cap company with associated risks and potential for growth.
Beta of -0.72 suggests a negative correlation with the market, potentially offering diversification benefits.

IVST提供哪些产品和服务？

Designs, engineers, tests, and manufactures curtain wall systems.
Supplies personal protection equipment, apparel, and safety supplies.
Offers inbound and outbound call services.
Negotiates and purchases various exterior building products.
Provides energy services to reduce businesses overall energy costs.
Offers LED lighting products.
Acts as an independent energy broker.
Develops immunotherapeutic for treating patients with glioblastoma multiforme.

IVST如何赚钱？

Generates revenue through the sale of curtain wall systems and related engineering services.
Earns income from the supply of personal protection equipment and safety supplies.
Provides energy services and earns commissions as an independent energy broker.
Seeks to generate revenue through the development and potential commercialization of immunotherapeutics.

Commercial and industrial construction companies requiring curtain wall systems.
Businesses seeking to reduce energy costs through energy services and LED lighting.
Organizations requiring personal protection equipment and safety supplies.
Patients and healthcare providers seeking innovative treatments for glioblastoma multiforme.

Diversified business operations across multiple sectors reduces reliance on a single market.
Proprietary designs and engineering expertise in curtain wall systems.
Established relationships with suppliers and customers in the energy and safety equipment sectors.
Potential for intellectual property protection related to its immunotherapeutic development.

什么因素可能推动IVST股价上涨？

Upcoming: Potential positive results from clinical trials of its immunotherapeutic for glioblastoma multiforme.
Ongoing: Expansion of energy services and securing new contracts.
Ongoing: Increased demand for curtain wall systems in commercial construction projects.
Ongoing: Strategic partnerships and acquisitions to expand market reach.

IVST的主要风险是什么？

Potential: Failure in clinical trials for its immunotherapeutic development.
Potential: Intense competition in all operating sectors.
Ongoing: Negative profit margin and financial instability.
Ongoing: OTC listing indicating higher risk and lower liquidity.
Potential: Economic downturn affecting construction and industrial demand.

IVST的核心优势是什么？

Diversified operations across multiple sectors.
Expertise in curtain wall systems design and engineering.
Potential for breakthrough in glioblastoma multiforme treatment.
Established presence in energy services and safety equipment supply.

IVST的劣势是什么？

Negative profit margin and financial instability.
OTC listing indicates higher risk and lower liquidity.
Limited market capitalization and brand recognition.
Dependence on external factors for energy services demand.

IVST有哪些机遇？

Expansion of energy services to meet growing demand.
Commercialization of immunotherapeutic for glioblastoma multiforme.
Increased demand for curtain wall systems in construction.
Strategic partnerships and acquisitions to expand market reach.

IVST面临哪些威胁？

Intense competition in all operating sectors.
Regulatory changes impacting energy and healthcare industries.
Economic downturn affecting construction and industrial demand.
Potential failure in clinical trials for immunotherapeutic development.

IVST的竞争对手是谁？

B China Corp — Focuses on business development in China. — (BCND)
China Business Corp — Offers business consulting services. — (CBCA)
LSC Communications Inc — Provides print and digital communication services. — (LSCG)
Meghmani Finechem Ltd — Manufactures chlor-alkali and its derivatives. — (MEGH)
Mingli Group Inc — Operates in the textile industry. — (MGLI)

Key Metrics

MoonshotScore: 45/100

Company Profile

CEO: Sri Vanamali
Headquarters: Chesterland, US
Founded: 2007

AI Insight

AI analysis pending for IVST

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Innovest Global, Inc. do?

Innovest Global, Inc. operates as a diversified conglomerate with a focus on commercial and industrial, energy, and biotechnology sectors. The company designs and manufactures curtain wall systems, supplies personal protective equipment, and offers energy services aimed at reducing energy costs for businesses. Additionally, Innovest Global is involved in the development of immunotherapeutics for treating glioblastoma multiforme, showcasing its diverse business model.

What do analysts say about IVST stock?

As of 2026-03-16, there is no readily available analyst coverage for Innovest Global, Inc. due to its OTC listing and small market capitalization. Investors should conduct their own due diligence and consider the company's financial challenges, growth opportunities, and inherent risks associated with OTC stocks. Key metrics to monitor include revenue growth, gross margin, and progress in its biotechnology initiatives.

What are the main risks for IVST?

The main risks for Innovest Global, Inc. include its negative profit margin, OTC listing indicating higher risk and lower liquidity, and the potential failure in clinical trials for its immunotherapeutic development. Additionally, the company faces intense competition in all operating sectors and is vulnerable to economic downturns affecting construction and industrial demand. Investors should carefully assess these risks before investing.